Decision Analysis Model of Prolonged Oral Anticoagulant Treatment in Factor v Leiden Carriers With First Episode of Deep Vein Thrombosis

BMJ
doi 10.1136/bmj.316.7125.95
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Residual Venous Obstruction in Patients With a Single Episode of Deep Vein Thrombosis and in Patients With Recurrent Deep Vein Thrombosis

Thrombosis and Haemostasis
Hematology
2005English

Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2007English

Effect of Factor v Leiden on Thrombosis in Childhood Leukemia

Open Journal of Blood Diseases
2013English

Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2015English

Remarkable Regression of Massive Deep Vein Thrombosis in Response to Intensive Oral Rivaroxaban Treatment

Thrombosis Journal
Hematology
2015English

The a -844g Polymorphism in the PAI-1 Gene Is Associated With a Higher Risk of Venous Thrombosis in Factor v Leiden Carriers

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2000English

The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor v Leiden and a First Spontaneous Venous Thromboembolism

Archives of Internal Medicine
2002English

Deep Vein Thrombosis

JAMA - Journal of the American Medical Association
Medicine
2015English

Deep Vein Thrombosis

AAOHN Journal
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy